Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study - PubMed (original) (raw)
Clinical Trial
Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study
G W Raborn et al. J Am Dent Assoc. 1987 Jul.
Abstract
A study of the effects of oral acyclovir (200 mg), administered five times per day for 5 days in 210 patients who cultured positive for herpes labialis, is made. A total of 149 patients were followed through three episodes each of herpes labialis while taking a placebo or acyclovir. Patients were evaluated for several clinical parameters, including the loss of lesion crust and reduction of the size of the area of the lesion between day 1 and day 5. Acyclovir showed a significant antiviral effect. Results show that oral acyclovir can favorably affect some parameters, but that higher doses or a "loading dose" could improve its efficacy.
Similar articles
- Treatment of herpes labialis with acyclovir. Review of three clinical trials.
Raborn GW, McGaw WT, Grace M, Percy J. Raborn GW, et al. Am J Med. 1988 Aug 29;85(2A):39-42. Am J Med. 1988. PMID: 3044091 Clinical Trial. - Treatment of recurrent herpes simplex labialis with oral acyclovir.
Spruance SL, Stewart JC, Rowe NH, McKeough MB, Wenerstrom G, Freeman DJ. Spruance SL, et al. J Infect Dis. 1990 Feb;161(2):185-90. doi: 10.1093/infdis/161.2.185. J Infect Dis. 1990. PMID: 2153735 Clinical Trial. - Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial.
Rooney JF, Straus SE, Mannix ML, Wohlenberg CR, Alling DW, Dumois JA, Notkins AL. Rooney JF, et al. Ann Intern Med. 1993 Feb 15;118(4):268-72. doi: 10.7326/0003-4819-118-4-199302150-00004. Ann Intern Med. 1993. PMID: 8380540 Clinical Trial. - Acyclovir in the management of herpes labialis.
Yeo JM, Fiddian AP. Yeo JM, et al. J Antimicrob Chemother. 1983 Sep;12 Suppl B:95-103. doi: 10.1093/jac/12.suppl_b.95. J Antimicrob Chemother. 1983. PMID: 6355056 Review. - Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections.
Van Vloten WA, Swart RN, Pot F. Van Vloten WA, et al. J Antimicrob Chemother. 1983 Sep;12 Suppl B:89-93. doi: 10.1093/jac/12.suppl_b.89. J Antimicrob Chemother. 1983. PMID: 6355055 Review.
Cited by
- Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
O'Brien JJ, Campoli-Richards DM. O'Brien JJ, et al. Drugs. 1989 Mar;37(3):233-309. doi: 10.2165/00003495-198937030-00002. Drugs. 1989. PMID: 2653790 Review. - Infectious Esophagitis.
Mulhall BP, Wong RK. Mulhall BP, et al. Curr Treat Options Gastroenterol. 2003 Feb;6(1):55-70. doi: 10.1007/s11938-003-0034-5. Curr Treat Options Gastroenterol. 2003. PMID: 12521573 - Clinical aspects and antiviral therapy in primary herpetic gingivostomatitis.
Amir J. Amir J. Paediatr Drugs. 2001;3(8):593-7. doi: 10.2165/00128072-200103080-00004. Paediatr Drugs. 2001. PMID: 11577924 Review. - Treatment and prevention of herpes labialis.
Opstelten W, Neven AK, Eekhof J. Opstelten W, et al. Can Fam Physician. 2008 Dec;54(12):1683-7. Can Fam Physician. 2008. PMID: 19074705 Free PMC article. Review. - Effect of foscarnet cream on experimental UV radiation-induced herpes labialis.
Bernstein DI, Schleupner CJ, Evans TG, Blumberg DA, Bryson Y, Grafford K, Broberg P, Martin-Munley S, Spruance SL. Bernstein DI, et al. Antimicrob Agents Chemother. 1997 Sep;41(9):1961-4. doi: 10.1128/AAC.41.9.1961. Antimicrob Agents Chemother. 1997. PMID: 9303394 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical